Medical Market Report

Global POC Diagnostics Market By Type (Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing and Others), By Application (Clinics, Hospitals, and Laboratory), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 134640
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on POC Diagnostics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global poc diagnostics market is segmented on the basis of Type, Application and geography.

    The worldwide market for POC Diagnostics Market is expected to grow at a CAGR of roughly x.x% over the next ten years and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    POC Diagnostics Market Scope:

    By type, the market is segmented into Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing and Cholesterol Testing. By Application, the market is divided into Clinics, Hospitals and Laboratory. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics and Trinity Biotech.

    Key Market Segments

    Type

    Blood Glucose Testing
    Infectious Diseases Testing
    Cardiac Markers Testing
    Coagulation Testing
    Pregnancy and Fertility Testing
    Blood Gas/Electrolytes Testing
    Tumor Markers Testing
    Urinalysis Testing
    Cholesterol Testing

    Application

    Clinics
    Hospitals
    Laboratory

    Key Market Players included in the report:

    Alere
    Roche
    Abbott Laboratories
    Johnson & Johnson
    Siemens Healthcare
    Danaher
    Bayer Healthcare
    Beckman Coulter
    Nipro Diagnostics
    Bio-Rad Laboratories
    Nova Biomedical
    BioMerieux
    Quidel
    Helena Laboratories
    OraSure Technologies
    Accriva
    Abaxis
    Chembio Diagnostics
    Trinity Biotech

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and POC Diagnostics Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of POC Diagnostics Market, high-growth regions, and market drivers, restraints and also market chances.
    The analysis covers POC Diagnostics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global POC Diagnostics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the POC Diagnostics Market together side their company profiles, SWOT analysis, latest advancements and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
    To know the POC Diagnostics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of POC Diagnostics sub-markets, depending on key regions (various vital states).
    To analyze POC Diagnostics Market concerning growth trends, prospects and also their participation in the entire sector.
    To examine and study the POC Diagnostics Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
    Primary worldwide POC Diagnostics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

  • Table Of Content 
    1. POC Diagnostics Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global POC Diagnostics Market Overview
    

    3.1. POC Diagnostics Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global POC Diagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global POC Diagnostics Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Blood Glucose Testing
    
4.4. Infectious Diseases Testing
    
4.5. Cardiac Markers Testing
    
4.6. Coagulation Testing
    
4.7. Pregnancy and Fertility Testing
    
4.8. Blood Gas/Electrolytes Testing
    
4.9. Tumor Markers Testing
    
4.10. Urinalysis Testing
    
4.11. Cholesterol Testing5. Global POC Diagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global POC Diagnostics Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Clinics
    
5.4. Hospitals
    
5.5. Laboratory6. Global POC Diagnostics Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America POC Diagnostics Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2. Europe
    

    6.2.1. Europe POC Diagnostics Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific POC Diagnostics Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America POC Diagnostics Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa POC Diagnostics Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global POC Diagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Alere
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Roche
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Abbott Laboratories
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. Johnson & Johnson
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Siemens Healthcare
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Danaher
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Bayer Healthcare
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. Beckman Coulter
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Nipro Diagnostics
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Bio-Rad Laboratories
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Nova Biomedical
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. BioMerieux
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments7.15. Quidel
    

    7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments7.16. Helena Laboratories
    

    7.16.1. Company Overview
    
7.16.2. Financial Highlights
    
7.16.3. Product Portfolio
    
7.16.4. SWOT Analysis
    
7.16.5. Key Strategies and Developments7.17. OraSure Technologies
    

    7.17.1. Company Overview
    
7.17.2. Financial Highlights
    
7.17.3. Product Portfolio
    
7.17.4. SWOT Analysis
    
7.17.5. Key Strategies and Developments7.18. Accriva
    

    7.18.1. Company Overview
    
7.18.2. Financial Highlights
    
7.18.3. Product Portfolio
    
7.18.4. SWOT Analysis
    
7.18.5. Key Strategies and Developments7.19. Abaxis
    

    7.19.1. Company Overview
    
7.19.2. Financial Highlights
    
7.19.3. Product Portfolio
    
7.19.4. SWOT Analysis
    
7.19.5. Key Strategies and Developments7.20. Chembio Diagnostics
    

    7.20.1. Company Overview
    
7.20.2. Financial Highlights
    
7.20.3. Product Portfolio
    
7.20.4. SWOT Analysis
    
7.20.5. Key Strategies and Developments7.21. Trinity Biotech
    

    7.21.1. Company Overview
    
7.21.2. Financial Highlights
    
7.21.3. Product Portfolio
    
7.21.4. SWOT Analysis
    
7.21.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.